Sort
10,766 grants matching “checkpoint inhibitor”
Noninvasive monitoring and evaluation of anti-tumor responses as a predictive tool
$191,276Mohammad Rashidian · Dana-Farber Cancer Inst · K22 · FY2020 · CA
Noninvasive monitoring and evaluation of anti-tumor responses as a predictive tool
$191,276Mohammad Rashidian · Dana-Farber Cancer Inst · K22 · FY2021 · CA
Novel small-molecule inhibitors of Wee1 kinase for medulloblastoma treatment
$191,193Philip Reigan · University Of Colorado Denver · R21 · FY2014 · NS
NCI-Alliance immune-related Adverse Events (irAE) Biorepository-Cures
$191,131James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Role of human endogenous retroviruses in tumor immunity of ovarian carcinoma
$191,044Katherine B Chiappinelli · George Washington University · R21 · FY2018 · CA
Designer EcN for treatment of solid tumors
$190,994Cammie Lesser · Massachusetts General Hospital · R21 · FY2023 · CA
Understanding how mitotic kinases drive EMT in breast cancers
$190,408Srikumar P Chellappan · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2019 · CA
PVSRIPO in melanoma
$190,389Georgia Beasley · Duke University · K08 · FY2023 · CA
Dynamic Analysis of Tumor and Microenvironment in Patients Undergoing Immunotherapy
$190,217Tanaya Shree · Oregon Health & Science University · K08 · FY2022 · CA
Dynamic Analysis of Tumor and Microenvironment in Patients Undergoing Immunotherapy
$190,217Tanaya Shree · Oregon Health & Science University · K08 · FY2024 · CA
Dynamic Analysis of Tumor and Microenvironment in Patients Undergoing Immunotherapy
$190,177Tanaya Shree · Oregon Health & Science University · K08 · FY2023 · CA
Mkp-1 suppresses immune checkpoint protein PD-L1 to prevent sepsis-associated immune dysfunction and mortality
$190,000Yusen Liu · Research Inst Nationwide Children'S Hosp · R21 · FY2020 · AI
First in Human Trials of ProAgio, a Cytotoxin
$189,995Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
CYTOKINE SIGNALING PATHWAYS REGULATING A G1 CHECKPOINT
$189,728University Of Iowa · R01 · FY2000 · CA
Targeting Ribosomal Biogenesis in Prostate Cancer
$189,681Everardo Macias · Cedars-Sinai Medical Center · K22 · FY2016 · CA
Discovery of PD-1/PDL-1 inhibitors from marine microbial natural products
$189,600William Fenical · University Of California, San Diego · R01 · FY2021 · CA
Airway Immune Response in Critically Ill Children-Precision Medicine in Children At Risk for Acute Respiratory Distress Syndrome
$189,485Jocelyn Rebecca Grunwell · Emory University · K23 · FY2022 · HL
A Novel Strategy of Targeting Transmembrane Protein to Improve KRAS-targeted Therapy
$189,338Wantong Yao · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · CA
Liposome-based mRNA cancer immunotherapy targeting ion channels
$189,338Laura Conforti · University Of Cincinnati · R21 · FY2023 · CA
Dissecting drug resistance in serial uveal melanoma biopsies using integrated, multi-modal single-cell profiling and novel machine learning tools.
$189,338Benjamin Izar · Columbia University Health Sciences · R21 · FY2021 · CA
Elucidating the role of tumor cell-intrinsic hypoxia inducible factor (HIF)-1α and HIF-2α pathway activation in tumor immune evasion
$189,195Jonathan A Trujillo · University Of Chicago · K08 · FY2025 · CA
Ex Vivo Profiling of Immunotherapy Combinations Using Organotypic Tumor Spheroids
$189,130Russell William Jenkins · Massachusetts General Hospital · K08 · FY2019 · CA
Ex Vivo Profiling of Immunotherapy Combinations Using Organotypic Tumor Spheroids
$189,130Russell William Jenkins · Massachusetts General Hospital · K08 · FY2020 · CA
Ex Vivo Profiling of Immunotherapy Combinations Using Organotypic Tumor Spheroids
$189,130Russell William Jenkins · Massachusetts General Hospital · K08 · FY2022 · CA
Ex Vivo Profiling of Immunotherapy Combinations Using Organotypic Tumor Spheroids
$189,130Russell William Jenkins · Massachusetts General Hospital · K08 · FY2018 · CA